ZNTL - Latest News
Zentalis Pharmaceuticals, Inc. (ZNTL), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $165.2M. Beta to the broader market is 1.94.
The article list below shows the most recent ZNTL headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ZNTL Headlines
Johnson & Johnson (NYSE:JNJ) & Zentalis Pharmaceuticals (NASDAQ:ZNTL) Head-To-Head Contrast
defenseworld.net - Oct 11, 2026
Zentalis Pharmaceuticals (NASDAQ: ZNTL - Get Free Report) and Johnson and Johnson (NYSE: JNJ - Get Free Report) are both healthcare companies, but whi
Comparing Zentalis Pharmaceuticals (NASDAQ:ZNTL) and Redhill Biopharma (NASDAQ:RDHL)
defenseworld.net - Oct 6, 2026
Redhill Biopharma (NASDAQ: RDHL - Get Free Report) and Zentalis Pharmaceuticals (NASDAQ: ZNTL - Get Free Report) are both small-cap healthcare compani
Leerink Partners Initiates Coverage on Zentalis Pharmaceuticals (NASDAQ:ZNTL)
defenseworld.net - Oct 5, 2026
Stock analysts at Leerink Partners started coverage on shares of Zentalis Pharmaceuticals (NASDAQ: ZNTL - Get Free Report) in a report released on Mon
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - Oct 1, 2026
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc.
This Small Biotech's Cancer Drug Could Reach $1.3 Billion In Peak Sales
benzinga.com - Sep 16, 2026
Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL) received a bullish initiation from William Blair on Tuesday, which sees a potential blockbuster opportuni
How News Affects ZNTL Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ZNTL's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ZNTL news questions
- What is the latest ZNTL news headline?
- The most recent ZNTL headline (Oct 11, 2026) is "Johnson & Johnson (NYSE:JNJ) & Zentalis Pharmaceuticals (NASDAQ:ZNTL) Head-To-Head Contrast". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ZNTL news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ZNTL news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ZNTL options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.